AL2846 capsules

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
34	Neurofibromatosis	1

34. Neurofibromatosis

Clinical trials : 133 / Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05011019 (ClinicalTrials.gov)	September 7, 2021	10/8/2021	A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsulesin Chinese Patients With Type ...	Phase Ib Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsulesin Chinese Patients Wi ...	Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors	Drug: AL2846 capsules	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	NULL	Recruiting	18 Years	75 Years	All	192	Phase 1/Phase 2	China

First Previous1Next Last